blisibimod (A-623) - Anthera
tabalumab (LY2127399) - Eli Lilly
Rituxan (rituximab) - Roche, Biogen
Epratucyn (epratuzumab) - Immunomedics
Benlysta (belimumab) - GSK
atacicept (TACI-Ig) - EMD Serono
http://www.ncbi.nlm.nih.gov/pubmed/31777515
 
Dec 1, 2019
 
Prev Next